Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening

被引：24
|
作者：
Williams, Christina D. [1 ,2 ]
Grady, William M. [3 ,4 ]
Zullig, Leah L. [5 ,6 ]
机构：
[1] Durham VA Med Ctr, Epidemiol Ctr Durham, Cooperat Studies Program, Durham, NC USA
[2] Duke Univ, Med Ctr, Div Med Oncol, Durham, NC USA
[3] Fred Hutchison Canc Res Ctr, Clin Res Div, Seattle, WA USA
[4] Univ Washington, Dept Med, Seattle, WA USA
[5] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA
[6] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 11期
关键词：
SERVICES TASK-FORCE; FECAL DNA; STOOL DNA; PROMOTER HYPERMETHYLATION; POTENTIAL BIOMARKER; AMERICAN-COLLEGE; COLON-CANCER; SERUM DNA; METHYLATION; POLYPS;
D O I：
10.6004/jnccn.2016.0154
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Colorectal cancer (CRC) remains a common cancer and significant public health burden. CRC-related mortality is declining, partly due to the early detection of CRC through robust screening. NCCN has established the NCCN Guidelines for CRC Screening to help healthcare providers make appropriate screening recommendations according to the patient's risk of developing CRC. This review describes the evolution of CRC screening guidelines for average-risk individuals, discusses the role of NCCN Guidelines for CRC Screening in cancer prevention, and comments on the current and emerging use of biomarkers for CRC screening.
引用
收藏
页码：1479 / 1485
页数：7
相关论文
共 50 条
  • [21] Colorectal cancer screening: A guide to the guidelines
    Deenadayalu, Vlju P.
    Rex, Douglas K.
    REVIEWS IN GASTROENTEROLOGICAL DISORDERS, 2007, 7 (04) : 204 - 213
  • [22] NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines
    Benson, Al B., III
    Venook, Alan P.
    Al-Hawary, Mahmoud M.
    Cederquist, Lynette
    Chen, Yi-Jen
    Ciombor, Kristen K.
    Cohen, Stacey
    Cooper, Harry S.
    Deming, Dustin
    Engstrom, Paul F.
    Garrido-Laguna, Ignacio
    Grem, Jean L.
    Grothey, Axel
    Hochster, Howard S.
    Hoffe, Sarah
    Hunt, Steven
    Kamel, Ahmed
    Kirilcuk, Natalie
    Krishnamurthi, Smitha
    Messersmith, Wells A.
    Meyerhardt, Jeffrey
    Miller, Eric D.
    Mulcahy, Mary F.
    Murphy, James D.
    Nurkin, Steven
    Saltz, Leonard
    Sharma, Sunil
    Shibata, David
    Skibber, John M.
    Sofocleous, Constantinos T.
    Stoffel, Elena M.
    Stotsky-Himelfarb, Eden
    Willett, Christopher G.
    Wuthrick, Evan
    Gregory, Kristina M.
    Freedman-Cass, Deborah A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (04): : 359 - 369
  • [23] NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
    Gradishar, William J.
    Anderson, Benjamin O.
    Balassanian, Ron
    Blair, Sarah L.
    Burstein, Harold J.
    Cyr, Amy
    Elias, Anthony D.
    Farrar, William B.
    Forero, Andres
    Giordano, Sharon Hermes
    Goetz, Matthew P.
    Goldstein, Lori J.
    Isakoff, Steven J.
    Lyons, Janice
    Marcom, P. Kelly
    Mayer, Ingrid A.
    McCormick, Beryl
    Moran, Meena S.
    O'Regan, Ruth M.
    Patel, Sameer A.
    Pierce, Lori J.
    Reed, Elizabeth C.
    Salerno, Kilian E.
    Schwartzberg, Lee S.
    Sitapati, Amy
    Smith, Karen Lisa
    Smith, Mary Lou
    Soliman, Hatem
    Somlo, George
    Telli, Melinda
    Ward, John H.
    Shead, Dorothy A.
    Kumar, Rashmi
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04): : 433 - +
  • [24] NCCN Guidelines® Insights Bladder Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
    Flaig, Thomas W.
    Spiess, Philippe E.
    Agarwal, Neeraj
    Bangs, Rick
    Boorjian, Stephen A.
    Buyyounouski, Mark K.
    Downs, Tracy M.
    Efstathiou, Jason A.
    Friedlander, Terence
    Greenberg, Richard E.
    Guru, Khurshid A.
    Noah Hahn
    Herr, Harry W.
    Hoimes, Christopher
    Inman, Brant A.
    Jimbo, Masahito
    Kader, A. Karim
    Lele, Subodh M.
    Meeks, Joshua J.
    Michalski, Jeff
    Montgomery, Jeffrey S.
    Pagliaro, Lance C.
    Pal, Sumanta K.
    Patterson, Anthony
    Petrylak, Daniel P.
    Plimack, Elizabeth R.
    Pohar, Kamal S.
    Porter, Michael P.
    Preston, Mark A.
    Sexton, Wade J.
    Siefker-Radtke, Arlene O.
    Tward, Jonathan
    Wile, Geoffrey
    Johnson-Chilla, Alyse
    Dwyer, Mary A.
    Gurski, Lisa A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1041 - 1053
  • [25] NCCN Guidelines® Insights Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines
    Clark, Peter E.
    Spiess, Philippe E.
    Agarwal, Neeraj
    Bangs, Rick
    Boorjian, Stephen A.
    Buyyounouski, Mark K.
    Efstathiou, Jason A.
    Flaig, Thomas W.
    Friedlander, Terence
    Greenberg, Richard E.
    Guru, Khurshid A.
    Hahn, Noah
    Herr, Harry W.
    Holmes, Christopher
    Inman, Brant A.
    Kader, A. Karim
    Kibel, Adam S.
    Kuzel, Timothy M.
    Lele, Subodh M.
    Meeks, Joshua J.
    Michalski, Jeff
    Montgomery, Jeffrey S.
    Pagliaro, Lance C.
    Pal, Sumanta K.
    Patterson, Anthony
    Petrylak, Daniel
    Plimack, Elizabeth R.
    Pohar, Kamal S.
    Porter, Michael P.
    Sexton, Wade J.
    Siefker-Radtke, Arlene O.
    Sonpavde, Guru
    Tward, Jonathan
    Wile, Geoffrey
    Dwyer, Mary A.
    Smith, Courtney
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10): : 1213 - 1224
  • [26] NCCN Guidelines® Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines
    Biermann, J. Sybil
    Chow, Warren
    Reed, Damon R.
    Lucas, David
    Adkins, Douglas R.
    Agulnik, Mark
    Benjamin, Robert S.
    Brigman, Brian
    Budd, G. Thomas
    Curry, William T.
    Didwania, Aarati
    Fabbri, Nicola
    Hornicek, Francis J.
    Kuechle, Joseph B.
    Lindskog, Dieter
    Mayerson, Joel
    McGarry, Sean V.
    Million, Lynn
    Morris, Carol D.
    Movva, Sujana
    O'Donnell, Richard J.
    Randall, R. Lor
    Rose, Peter
    Santana, Victor M.
    Satcher, Robert L.
    Schwartz, Herbert
    Siegel, Herrick J.
    Thornton, Katherine
    Villalobos, Victor
    Bergman, Mary Anne
    Scavone, Jillian L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (02): : 155 - 167
  • [27] Guidelines for the use of biomarkers in breast cancer
    Duffy, M. J.
    TUMOR BIOLOGY, 2007, 28 : 38 - 38
  • [28] International Adaptation and Use of NCCN Guidelines
    Bazarbachi, Ali
    Zelenetz, Andrew D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (5.5): : 838 - 841
  • [29] Lung Cancer Screening, Version 1.2015 Featured Updates to the NCCN Guidelines
    Wood, Douglas E.
    Kazerooni, Ella
    Baum, Scott L.
    Dransfield, Mark T.
    Eapen, George A.
    Ettinger, David S.
    Hou, Lifang
    Jackman, David M.
    Klippenstein, Donald
    Kumar, Rohit
    Lackner, Rudy P.
    Leard, Lorriana E.
    Leung, Ann N. C.
    Makani, Samir S.
    Massion, Pierre P.
    Meyers, Bryan F.
    Otterson, Gregory A.
    Peairs, Kimberly
    Pipavath, Sudhakar
    Pratt-Pozo, Christie
    Reddy, Chakravarthy
    Reid, Mary E.
    Rotter, Arnold J.
    Sachs, Peter B.
    Schabath, Matthew B.
    Sequist, Lecia V.
    Tong, Betty C.
    Travis, William D.
    Yang, Stephen C.
    Gregory, Kristina M.
    Hughes, Miranda
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (01): : 23 - 34
  • [30] Reproducibility of guidelines - A comparison of the NCCN and ASCO lung cancer guidelines
    Winn, RJ
    Brown, NH
    Botnick, WZ
    ONCOLOGY-NEW YORK, 1999, 13 (5A): : 35 - 39
12345